Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
65.4M
-
Shares change
-
+4.09M
-
Total reported value, excl. options
-
$486M
-
Value change
-
+$35.8M
-
Put/Call ratio
-
0.59
-
Number of buys
-
65
-
Number of sells
-
-71
-
Price
-
$7.43
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q3 2020
158 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q3 2020.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.4M shares
of 374M outstanding shares and own 17.47% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (5.65M shares), BlackRock Inc. (5.37M shares), Neuberger Berman Group LLC (4.36M shares), Indaba Capital Management, L.P. (3.96M shares), ORBIMED ADVISORS LLC (3.55M shares), VANGUARD GROUP INC (3.53M shares), Atom Investors LP (3.21M shares), MILLENNIUM MANAGEMENT LLC (3.07M shares), FMR LLC (3.01M shares), and RENAISSANCE TECHNOLOGIES LLC (2.21M shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.